Article
Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia
1 Sept 2012
Abstract excerpt
OBJECTIVE: MicroRNA-100 (miR-100), a small noncoding RNA molecule, acts as a tumor suppressor or an oncogene in different cancers. The aberrant expression of this microRNA has been demonstrated as a frequent event in adult patients with acute myeloid leukemia (AML), but little is known for pediatric AML. The aim of this study was to investigate the expression and clinical significance of miR-100 in pediatric AML....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
